University of North Dakota

UND Scholarly Commons
Physician Assistant Scholarly Project Posters

Department of Physician Studies

2018

The Effectiveness of Oral Non-Steroidal AntiInflammatories versus Steroid Injections in Patients
with Shoulder Pain
Darren Scott Pledger
University of North Dakota

Follow this and additional works at: https://commons.und.edu/pas-grad-posters
Part of the Orthopedics Commons
Recommended Citation
Pledger, Darren Scott, "The Effectiveness of Oral Non-Steroidal Anti-Inflammatories versus Steroid Injections in Patients with
Shoulder Pain" (2018). Physician Assistant Scholarly Project Posters. 20.
https://commons.und.edu/pas-grad-posters/20

This Poster is brought to you for free and open access by the Department of Physician Studies at UND Scholarly Commons. It has been accepted for
inclusion in Physician Assistant Scholarly Project Posters by an authorized administrator of UND Scholarly Commons. For more information, please
contact zeineb.yousif@library.und.edu.

The Effectiveness of Oral Non-Steroidal Anti-Inflammatories Versus Steroid
Injections in Patients with Shoulder Pain
Darren Pledger PT, DPT, PA-S

Statement of the Problem
• The fact that shoulder pain is the third most common
musculoskeletal complaint in primary care shows that clinicians
must have an arsenal of quality interventions to treat this
problem.
• The need for quality research and evidenced based guidelines
are necessary to educate clinicians on their treatment options,
the efficacy of those treatments, and their safety profiles.

Research Questions
1. In patients with shoulder pain, is oral non-steroidal antiinflammatories or corticosteroid injections into the glenohumeral
joint more effective in reducing shoulder pain?
2. What are the risks and side effects of oral non-steroidal antiinflammatories and corticosteroid injections into the glenohumeral
joint when used to treat shoulder pain?

Literature Review
Theme 1
• Adebajo, Nash, and Hazleman, (1990), found both oral NSAIDs
(p=0.0268) and triamcinolone injection are superior to placebo
with the steroid injection group achieving the greatest results.
• Berry, Fernandes, Bloom, Clark, and Hamilton (1980) found
that all groups showed statistically significant improvement in
pain and range of motion but no significant difference between
groups with no distinct advantage of any treatment.
• Petri, Dobrow, Neiman, Whiting-O'keefe, and Seaman (1987)
found that steroid injection (p=0.00005) and oral NSAIDs
(p=0.02) were statistically superior to placebo and that there
was no statistical significance of combined treatment compared
to steroid injection alone.

Literature Review
• Ranalletta et al. found that pain was improved at all time points
regardless of treatment group. However, relief was achieved
faster in the corticosteroid injection group. This was
statistically significant up to eight weeks (p=<.001), but lost
significance (p=.825) at 12 weeks as pain improved in the oral
NSAID group.
• Shin and Lee (2013) found that all patients treated with
corticosteroids, regardless of group, demonstrated statistically
significant (p=<.05) faster pain relief and functional recovery
up to 16 weeks compared to oral NSAIDs. Although
corticosteroids were found to achieve faster results, at 24 weeks
there was no statistical difference (p=.670) in outcomes for all
four groups.
• Sun, Chen, Li, Jiang, and Chen (2015) found that in terms of
functional improvement, steroid injections showed superiority
to oral NSAIDs (standard mean difference (SMD) 0.61; 95%CI,
0.08–1.14, p=0.01) and found no superiority in either treatment
in pooled results in regard to pain relief (SMD 0.45;
95%CI,0.50–1.40, p<0.00001).
Theme 2
• Nissen et al. (2016), Precision Trial, found statistically
significant results that there is no greater cardiovascular risk
from celecoxib when compared to naproxen or ibuprofen.
• Castellsague et al. (2012), for individual NSAID use, they
determined that ibuprofen was in the lowest range of pooled
RRs while naproxen was associated with higher RR values
depending on certain doses.
• Zhang, Donnan, Bell, and Guthrie (2017) found that taking
NSAIDs was associated in a 1.5-fold increase in the odds of
developing AKI in the general population in people with (OR
1.63, 95%CI: 1.22–2.19, p=0.009) and without CKD (OR 1.73
95%CI: 1.44–2.07, p < 0.001).
• Patrono (2016) determined that traditional NSAIDS and coxibs
increased the risk of major vascular events by 40% with the
exception of naproxen.
• Rostom et al. (2011) found a clear advantage of selective COX2s over nonselective NSAIDs on gastrointestinal safety with
fewer gastroduodenal ulcers (RR 0.26, 95%CI: 0.23-0.30) and
fewer complications from ulcers (RR 0.39, 95%CI: 0.31-0.50).

References

Discussion
• Many of the studies comparing corticosteroids to oral NSAIDs
yielded similar results (Berry et al., 1980; Deghan et al., 2013;
Petri et al., 1987; Ranelleta et al., 2016; Sun et al., 2015).
• Two studies found that corticosteroids and oral NSAIDs are
both superior to placebo in treating shoulder pain (Adebajo et
al., 1990; Petri et al., 1987).
• Three studies found with statistical significance, that
corticosteroids accelerate pain relief when compared to oral
NSAIDs but long-term pain relief was equivocal (Dehghan et
al., 2013; Ranelleta et al., 2016; Shin & Lee, 2013).
• Many of the studies in theme one had very small sample sizes.
• There is a small amount of literature directly comparing oral
NSAIDs to corticosteroid injection.
• A wide range of shoulder conditions were studied in theme one
lacking consistency.
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• Many studies in theme one were dated.
• There is a risk for upper gastrointestinal complications
(Castellsague et al., 2012; Chang et al., 2011; Garcia
Rodriquez & Barreales Tolosa, 2007; Rostom et al., 2011;
Nissen et al., 2016).
• Non-selective oral NSAIDs pose the greatest risk followed by
selective oral NSAIDs. Although selective oral NSAIDs were
found to decrease the risk of upper gastrointestinal
complications, they found that taking aspirin with selective
NSAIDs virtually cancels out their gastroprotective effect
(Garcia Rodriquez & Barreales Tolosa, 2007)
• The studies showed an increase in cardiovascular risk to a
varying degree of all NSAIDs (Chang et al., 2011; Nissen et
al., 2016; Patrono, 2016).
• All NSAIDs pose a risk to the kidney and AKI is possible in
healthy populations as well as the elderly (Chou et al., 2016;
Zhang et al., 2017).

Conclusion
• Both oral NSAIDs and corticosteroid injection are effective in
reducing shoulder pain.
• Both treatments can treat a wide range of conditions.
• Both are superior to placebo while neither is superior to the
other, thus the decision on what treatment to use should be
based on an individuals comorbidities and risk factors.
• There are side effects associated with both treatments.
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